Validation cohort of a tool to predict proliferative histological class in lupus nephritis based on clinical and laboratory data: LUCAS Study (Lupus Nephritis Class Assessment System).
Antonio Silaide Araujo, Emilia Inoue Sato, Alexandre Wagner Silva de Souza, Fábio Jennings, Gianna Mastroianni Kirsztajn, Ricardo Sesso, Edgard Torres Dos Reis-Neto
{"title":"Validation cohort of a tool to predict proliferative histological class in lupus nephritis based on clinical and laboratory data: LUCAS Study (Lupus Nephritis Class Assessment System).","authors":"Antonio Silaide Araujo, Emilia Inoue Sato, Alexandre Wagner Silva de Souza, Fábio Jennings, Gianna Mastroianni Kirsztajn, Ricardo Sesso, Edgard Torres Dos Reis-Neto","doi":"10.1136/lupus-2025-001538","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Primary: To validate a previously developed lupus nephritis (LN) histologic class predictor tool (III or IV±(V) vs V). In this instrument, urinary sediment, anti-dsDNA antibody and serum creatinine were predictor variables. Secondary: To evaluate its accuracy in different cut levels of urinary red cell count and LN patient's profile that may be useful to guide diagnosis and treatment, especially when kidney biopsy is not available.</p><p><strong>Methods: </strong>A retrospective, cross-sectional study of 196 patients with SLE who underwent kidney biopsy, analysing sensitivity, specificity, positive and negative predictive values, accuracy, and positive and negative likelihood ratios.</p><p><strong>Results: </strong>81.6% of the patients were female, 60.2% were non-Caucasian and the mean age at the time of the biopsy was 31.2±10.4 years. 30 patients presented class III, 104 class IV, 36 class V and 26 mixed classes (7 class III+V and 19 class IV+V). In the validation cohort, sensitivity was 90.6%, specifically was 66.7%, positive predictive value was 92.4% and accuracy was 86.2%, in predicting proliferative classes (class III or IV(±V) vs class V). There was no difference when analysing urinary red cell counts >5 x 10<sup>3</sup>/mL, >10 x 10<sup>3</sup>/mL or >20 x 10<sup>3</sup>/mL, as well as when the tool was applied in the first or recurrent LN and in proliferative LN without class V.</p><p><strong>Conclusions: </strong>The validation of a tool to predict proliferative histologic class showed good performance, like that found in the development cohort, without difference in accuracy with different cut-off points for urinary red cell count or number of flares of LN. It is easily applied and can be accessed via the internet (https://nefritelupica.medicalcore.com.br).</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"12 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12039031/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2025-001538","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Primary: To validate a previously developed lupus nephritis (LN) histologic class predictor tool (III or IV±(V) vs V). In this instrument, urinary sediment, anti-dsDNA antibody and serum creatinine were predictor variables. Secondary: To evaluate its accuracy in different cut levels of urinary red cell count and LN patient's profile that may be useful to guide diagnosis and treatment, especially when kidney biopsy is not available.
Methods: A retrospective, cross-sectional study of 196 patients with SLE who underwent kidney biopsy, analysing sensitivity, specificity, positive and negative predictive values, accuracy, and positive and negative likelihood ratios.
Results: 81.6% of the patients were female, 60.2% were non-Caucasian and the mean age at the time of the biopsy was 31.2±10.4 years. 30 patients presented class III, 104 class IV, 36 class V and 26 mixed classes (7 class III+V and 19 class IV+V). In the validation cohort, sensitivity was 90.6%, specifically was 66.7%, positive predictive value was 92.4% and accuracy was 86.2%, in predicting proliferative classes (class III or IV(±V) vs class V). There was no difference when analysing urinary red cell counts >5 x 103/mL, >10 x 103/mL or >20 x 103/mL, as well as when the tool was applied in the first or recurrent LN and in proliferative LN without class V.
Conclusions: The validation of a tool to predict proliferative histologic class showed good performance, like that found in the development cohort, without difference in accuracy with different cut-off points for urinary red cell count or number of flares of LN. It is easily applied and can be accessed via the internet (https://nefritelupica.medicalcore.com.br).
目的:主要:验证先前发展的狼疮性肾炎(LN)组织学分级预测工具(III或IV±(V) vs V)。在该仪器中,尿沉渣、抗dsdna抗体和血清肌酐是预测变量。次要:评估其在不同切口水平的尿红细胞计数和LN患者概况中的准确性,这可能有助于指导诊断和治疗,特别是在没有肾活检的情况下。方法:对196例行肾活检的SLE患者进行回顾性横断面研究,分析敏感性、特异性、阳性和阴性预测值、准确性以及阳性和阴性似然比。结果:81.6%的患者为女性,60.2%为非白种人,活检时的平均年龄为31.2±10.4岁。III级30例,IV级104例,V级36例,混合级26例(III+V级7例,IV+V级19例)。在验证队列中,预测增殖类别(III类或IV类(±V) vs V类)的敏感性为90.6%,特异性为66.7%,阳性预测值为92.4%,准确性为86.2%。没有区别在分析尿红细胞计数> 5 x 103 /毫升> 10 x 103 /毫升或> 20 x 103 /毫升时,以及当工具应用在第一或复发性LN和增生性LN没有类V.Conclusions:工具的验证预测增生的组织学类显示良好的性能,开发群体中发现的那样,没有精度的差异与不同的截止点尿红细胞计数或LN的耀斑。它很容易应用,可以通过互联网(https://nefritelupica.medicalcore.com.br)访问。
期刊介绍:
Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.